Upgrade to SI Premium - Free Trial

BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $108 at BMO Capital

August 5, 2020 9:46 AM
BMO Capital analyst George Farmer raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $108.00 (from $94.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles